The Adverse Drug Reactions, Drug Interactions and Pharmacovigilance course is a one-week module of the MSc in Experimental Therapeutics. Offered by the Department of Oncology and the Department for Continuing Education, the teaching will be led by Dr Michael Theodorakis, Radcliffe Department of Medicine, University of Oxford, and will feature face-to-face lectures and tutorials from some of the country's leading clinicians and scientists.
The module can be taken as a stand-alone short course. It includes group work, discussions, guest lectures, and interaction and feedback with tutors and lecturers.
The Adverse Drug Reactions, Drug Interactions and Pharmacovigilance course will provide students with the opportunity to learn more about and discuss the following topics:
- Safety of medicines for human use – principles and framework
- Adverse drug reactions – mechanisms, analysis, reporting, vulnerable populations
- Drug interactions – epidemiology, mechanisms, detection and prevention
- Principles of optimal pharmacotherapy
- Pharmacovigilance – principles, methodologies, risk management & pharmacoepidemiology
- Clinical trials – bioethics of drug safety, pharmacovigilance in trial design, applications for marketing authorisation
- Regulatory framework and legislation